GRAPPA 2024 年次総会からのワークショップ
Maria-Angeliki Gkini1, Lyn Chinchay2, Chris A Lindsay3
1M.A. Gkini, MD, PhD, MSc, Department of Dermatology, Barts Health NHS Trust, London, UK.
The Journal of rheumatology
|September 1, 2025
まとめ
病理学者は,牛皮質関節炎 (PsA) の併発症と牛皮質病 (PsO) を区別し,効果的な患者管理のための実践的な結果測定法を使用する必要があります. 模倣症状を早期に認識し,皮膚科医に間に合うように紹介することは,正確な診断と治療に不可欠です.
科学分野:
- 皮膚科とリウマチ科
- クリニカル・プラクティスのガイドライン
- 患者の成果の測定
背景:
- 非皮膚科医は,しばしば,牛皮質関節炎 (PsA) の患者において,牛皮質関節炎 (PsO) を模倣する皮膚疾患を誤診する.
- 正確な診断は,病気の重症度を評価し,PsA患者の治療決定を導くために不可欠です.
- よく誤解される症状には,チネア,セボレア性皮膚炎,エクゼマ,ピチリアシス・ルブラ・ピラリス,梅毒,皮膚リンパ腫があります.
研究 の 目的:
- 他の皮膚疾患とPSAに関連する皮膚症状の区別について,リウマトロジストを教育する.
- 臨床環境における疾病負担の評価のための実用的な成果測定をレビューする.
- PsAの皮膚関わりの管理のための治療対象アプローチを促進します.
主な方法:
- GRAPPA 2024年会では,リウマチ科医のための2つのパートのワークショップが開催されました.
- 第1部では 牛皮病を模倣する皮膚疾患を紹介しました
- 第2部では,臨床実務に適した結果の評価に焦点を当てました.
主要な成果:
- このワークショップは,PsA患者の皮膚疾患の診断の精度を向上させることを目的としています.
- 忙しい臨床環境でのPASIとDLQIの限界を強調した.
- 医者の総合評価 (PGA),ハンドプリント BSA,非公式の患者報告の結果は,実用的なツールとして特定されました.
結論:
- 統合失調症の併発症と統合失調症の併発症を区別することは,関節病学者に極めて重要です.
- PGAのような実用的な結果測定は,臨床実務におけるPsAの管理に価値があります.
- クリア/ほぼクリアのPGAを狙ったトリートメント・トゥ・ターゲットの戦略が推奨されます.
関連する概念動画
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
57
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
34
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
34
01:26Nephrotic Syndrome II : Assessment and Medical Management
21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21
01:11Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
01:21Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K